Watch Demo

The United Arab Emirates Antidiabetics Industry Outlook 2024 - 2028

See how the United Arab Emirates Antidiabetics performed compared to key markets.

Key Market Indicators

Emirati Insulin Imports are projected to soar to approximately $116 million by 2028, up from around $103 million in 2023. This represents an annual growth rate of 1.8%, according to recent data. Since 2012, the demand for insulin in the UAE has increased at an average annual rate of 2.2%. On the export front, the UAE's insulin exports are expected to reach about $66 million by 2028, growing from roughly $52 million in 2023. This marks an impressive annual growth rate of 3.8%. Since 2012, the country's insulin supply has surged by an average of 5.1% per year. In 2023, the UAE ranked 11th in global insulin exports, with the Czech Republic surpassing it at the same export value of $52 million. France, Italy, and China secured the second, third, and fourth spots, respectively, in the global ranking for insulin exports.

Marketing Banner

The United Arab Emirates Antidiabetics Market Data and Forecasts

How much will the United Arab Emirates Antidiabetics Market grow to 2028?

Forecast: Import of Insulin in Dosage Forms to the UAE
Forecast: Export of Insulin in Dosage Forms from the UAE
Forecast: Re-Export of Insulin in Dosage Forms from the UAE
Forecast: Re-Export of Insulin from the UAE
Forecast: Export of Insulin from the UAE
More in Antidiabetics Industry for 2028